Artemis One Health Research Foundation- One health approach to infectious diseases

THE MISSION OF ARTEMIS ONE HEALTH:

Our mission is to make a DIFFERENCE in the lives of humans and animals by performing innovative and translational research, with the ultimate goal to develop SAFE, EFFECTIVE, and AFFORDABLE vaccines against neglected infectious diseases.

HELP US IMPROVE HUMAN HEALTH AND ANIMAL HEALTH.

Let us bring change & hopeby understanding diseases through biomedical research.

 

RESEARCH ON INFECTIOUS DISEASES

We aim at undertaking fundamental and applied interdisciplinary research on infectious disease to improve human, animal and ecosystem health.

We unravel mechanisms of pathogenesis, cross-species transmission and spread to developing effective intervention strategies. Artemis One Health Research Foundation is a non-profit organization devoted to advancing knowledge on infectious diseases that affect humans and other animals.

Artemis One Health Research Institute recognizes that the health of humans, animals and ecosystems are interconnected and is therefore devoted to apply state-of-the-art interdisciplinary and trans-disciplinary research on infectious diseases to improve human, animal and ecosystem health.

RESEARCH DOMAIN

Virus ecology
Pathogenesis
Intervention strategies

OUR KEY FOCUS

Zoonotic
Arboviruses
Valorization
Animal

FOLLOW US ON:

HOW CAN YOU HELP?       

Become an ambassador      
Donate      
Volunteer      
Partnership

RESEARCH FUNDING

Grants
Private funding
Public funding

OUR VALUES           

Commitment      
Innovation      
Reliable        
Partnership

INTRODUCING OUR WORK 

INTRODUCING THE WORK OF ARTEMIS ONE HEALTH

ARTEMIS’ KEY FOCUS:

Zoonotic viruses
Zoonotic virus infections place a huge burden on society in terms of disease burden and mortality, and … > READ MORE

Arbovirus
More than one billion people living in the world’s poorest countries suffer from at least one neglected tropical disease, which can cause significant emotional distress, morbidity and mortality… > READ MORE

Valorization
“Health systems in many disease endemic countries are noticeably weak. Patients either cannot afford or do not have access to adequate drugs, while human and other resources are overburdened by the volume of needs… > READ MORE

Animal
Viruses also pose a threat to livestock and wildlife, thereby affecting the economy and endangering public health. Understanding viral diseases in domestic animals and wildlife is essential… > READ MORE

 OUR RESEARCH PROJECTS:

View ALL “ONGOING” research projects:

Compare | Chikungunya | Yellow fever | Zika | Elephant Herpes virus |  Rabies | Influenza |  Dengue EcoAlert Zapi |  Flucop | Flunivac | TBEV-COMEIN

GRANT-DRIVEN RESEARCH PROJECTS

projects

 View FINISHED projects

WHAT WE DO

About Artemis

Artemis One Health Research Institute is defined by its vision, mission, and aims, formulated to achieve innovation that matters.

Research & Highlights

Read about our research on virus ecology, mechanisms of disease and intervention strategies. Read all about the progress in Artemis’ research and other highlights in the field.

Valorization

To  bring affordable and effective products on the market, Artemis investigates barriers to innovations and develops strategies to overcome these barriers and stimulate marketing of affordable products.

Meet our researchers

Our team consist of diverse research disciplines. Bringing together leading experts in virology, pathology, immunology and other science specialities.

RESEARCH PROJECTS

LEARN MORE ABOUT OUR “ONGOING” RESEARCH PROJECTS

COMPARE 
<< ZOONOTIC>>
Compare is a consortium consisting of various institutions from different EU countries and subsidized by the European Commission. This consortium is working to develop a platform that allows rapid identification of new infectious diseases… > LEARN MORE

ZAPI
<< ZOONOTIC >>
Zapi is an EC subsidized consortium consisting of several public and private institutions. This consortium aims at developing a platform that allows rapid identification of new viral diseases and rapid development of vaccines against these newly emerging viruses… > LEARN MORE

FLUCOP
<< ZOONOTIC >>
Flucop is a consortium of public and private partners that work together to define the part of the immune system that is most important in providing protection against influenza virus… > LEARN MORE

FLUNIVAC
<< ZOONOTIC >>
Flunivac is an EC subsidized consortium consisting of several public and private institutions. The aim of this consortium is to develop an universal vaccine against influenza virus, which would eliminate the need to change the composition of the vaccine every year… > LEARN MORE

YELLOW FEVER
<< ARBOVIRUS >>
Yellow fever virus has the potential to cause big (urban) epidemics as exemplified by the situation before 1950s. However, the majority of the reported outbreaks to date are mainly seen in Africa and South America and have a forest (sylvatic) origin… > LEARN MORE

 

ECOALERT
<< ARBOVIRUS >>
Arbovirus outbreaks are widespread, unexplained and unpredictable. This makes current surveillance approaches focusing on Arbovirusesindividual diseases and exotic vector populations inadequate, financially unsustainable, and unsatisfying for decision making by public health officials in early stages of emergence… > LEARN MORE

DENGUE
<< ARBOVIRUS >>
Dengue virus (DENV) infection is a huge and growing problem in tropical and subtropical areas of the world. Approximately 390 million people are infected annually worldwide with DENV, which may develop into severe disease, characterized by shock and multi-organ failure (MOF), especially in children… > LEARN MORE

CHIKUNGUNYA
<< ARBOVIRUS >>
Chikungunya virus (CHIKV) is transmitted to people by mosquitoes, the same mosquitoes that transmit dengue and Zika. Historically distributed across tropical Africa and Southeast Asia, CHIKV has in recent years expanded its geographical range across the Indian Ocean and lately across South America and the Caribbean… > LEARN MORE

TBEV-COMEIN
<< ARBOVIRUS >>
Ticks are able to transmit a wide range of diseases to both humans and animals, including Lyme’s disease and tick-borne encephalitis (TBE). TBE, a disease caused by the tick-borne encephalitis virus (TBEV), is often associated with neurological symptoms in humans… > LEARN MORE

 

RABIES
<< VALORIZATION >>
Rabies virus (RABV), a member of the Lyssavirus genus is transmitted by the bite or scratches of infected animals (primarily dogs but also by cats, wildlife and bats), causes rabies encephalitis and accounts for more than 55,000 reported fatal human cases each year… > LEARN MORE

 

INFLUENZA
<< VALORIZATION >>
A universal influenza vaccine is one of the largest unmet medical needs. Yearly 250,000 to 500,000 people die from seasonal influenza, and on average 3 to 5 million hospitalizations occur each year… > LEARN MORE

ELEPHANT HERPESVIRUS
<< ANIMAL >>
The high mortality rates associated with elephant herpesvirus (EEHV) infections in captive and wild elephants and the threat they pose to the continuation and success of captive breeding programs for the highly endangered Asian elephant in both North America and Europe, makes the development of a safe and effective vaccine a high priority. .. > LEARN MORE

 

HOW CAN YOU HELP!

GIVE A LITTLE, CHANGE A LOT

At Artemis we unravel mechanisms of pathogenesis, cross-species transmission and spread in order to develop effective intervention strategies.

We have designed some charity projects that need your immediate attention!

WHAT EXPERTS SAY

Byron Martina

Although it is extremely important to develop innovative tools and technologies to study the pathogenesis and develop new intervention strategies, like the use of vaccines, diagnostics, and therapeutics to combat viral diseases, currently there is too little funding available to realize this. The perceived lack of a market and return on investment appear to be the main reasons why companies are not investing in developing them.

Dr. B. Martina

Ab Osterhaus

Improve the health of our planet

”Interdisciplinary research on the mechanisms of pathogens’ ecology, evolution and pathogenesis is a fundamental pillar for improving the health of our planet, its residents, and for designing effective intervention strategies against infectious diseases”.

Prof.Dr. A. Osterhaus

SEE ALL OUR SCIENTIFIC PUBLICATIONS

We enhance scientific knowledge through fundamental and applied research addressing scientific and societal challenges.

RECENT AWARDS:

Prof. Dr. Albertus (Ab) Osterhaus

  • 2016 Doctorate h.c. University Liege, Belgium
  • 2015 Chanchiani Global Health Research Award (McMaster, USA)
  • 2012 WSAVA One Health Award for cross-species viral infection
  • 2010 ESCMID Award for Excellence in Clinical Microbiology and Infectious Diseases
  • 2008 Erasmus Award, Erasmus MC Rotterdam, The Netherlands
  • 2007 Allan Granoff Lectureship in Virology Award, St. Jude’s Hospital
  • 2007 Prix scientifique Louis D – Académie des sciences de l’Institut de France
  • 2006 European Respiratory Society – European Lung Foundation Award

section-free-creative-child-themes

OUR PARTNERS

Wageningen university
Utrecht University
one-health-platform

MEET OUR DEDICATED TEAM

Byron Martina

Director & Chief Scientific Officer

Ab Osterhaus

Scientific advisor

Leslie Seperant

Acquisition Manager/Research scientist

Ruud van Hofwegen

Chief Financial Officer

Jeroen Roose

Senior technician/ Operation Officer

Stephanie Lim

Post-doc

Eveline Gouw

PhD Student

Eurydice Martina

Fundraising Officer

The world is a global village when it comes to infectious diseases and now more than ever, we should invest in global health. Become one of the financial partners who support our research in infectious diseases, affecting humans, animals and ecosystems.

Learn how you can help

Contact us and
Partner up!

Thanks for your interest. We would be very happy to establish a partnership with you, as we see it beneficial for both parties. If you are interested in working with us, contact:

Dr. Byron Martina – Head Research & Development of Artemis One Health Research Foundation
E-mail: b.martina@artemisonehealth.com
Office phone: +31 (0)30 635 5444

consent

Please feel free to contact us if you have any suggestions for research, questions about our projects, or simply if you would like our advice. We respect your privacy and All information received will always remain confidential. We will try to respond to you within 3-5 working days. For urgent enquiries please call: +31 (0)30 635 5444.

ADDRESS:
Molengraaffsingel 10
2629 JD Delft
The Netherlands

MAIL:
info@artemisonehealth.com

Partner with us!

Or feel free to fill in our partnership contact form. We will respond to you within 48 hours..